Daiwa Securities Group
ORTX

Daiwa Securities Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Daiwa Securities Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,326
Closed -$30K – 1467
2021
Q3 		$30K Buy
1,326
+1,313
+10,100% +$39.1K ﹤0.01% 1086
2021
Q2 		$1K Hold
13
– – ﹤0.01% 1235
2021
Q1 		$1K Hold
13
– – ﹤0.01% 1246
2020
Q4 		$1K Sell
13
-18
-58% -$806 ﹤0.01% 1228
2020
Q3 		$1K Hold
31
– – ﹤0.01% 1173
2020
Q2 		$2K Hold
31
– – ﹤0.01% 1171
2020
Q1 		$2K Buy
31
+9
+41% +$1.04K ﹤0.01% 1173
2019
Q4 		$3K Buy
+22
New +$2.67K ﹤0.01% 1152

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Daiwa Securities Group's ORTX Position: Q4 2021 in Review

Daiwa Securities Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 1,326 shares — an estimated $30K sold.

Daiwa Securities Group first reported a position in ORTX in Q4 2019 and held it in 8 quarters. The position peaked at $30K in Q3 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Daiwa Securities Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 1,326 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $30K.
  • Daiwa Securities Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 8 quarters.
  • Daiwa Securities Group's Orchard Therapeutics plc American Depositary Shares position peaked at $30K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.